Allogenic stem cell transplantation as salvage therapy for patients relapsing after autologous transplantation: Experience from a single institution

Leukemia Research

Volumn 25, Issue 5, 2001, Pages 379-384

  Martínez, Carmen ^a   Carreras, Enric ^a   Rovira, Montserrat ^a   Urbano Ispizua, Álvaro ^a   Esteve, Jordi ^a   Fernández Avilés, Françesc ^a   Perales, María ^a   Rives, Susana ^a   Gómez, Marta ^a   Montserrat, Emilio ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Allogenic transplantation; Autologous transplantation; Relapse

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; MELPHALAN; METHOTREXATE;

ADULT; ARTICLE; AUTOTRANSPLANTATION; CANCER CHEMOTHERAPY; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONDITIONING; FEMALE; GRAFT VERSUS HOST REACTION; HODGKIN DISEASE; HUMAN; INFECTION COMPLICATION; LEUKEMIA; LYMPHATIC SYSTEM TUMOR; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; SALVAGE THERAPY; STEM CELL TRANSPLANTATION;

ADULT; DISEASE PROGRESSION; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; SALVAGE THERAPY; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0035066839     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(00)00146-6     Document Type: Article

References (22)

1. Therapy of acute myelogenous leukemia
2. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma
3. Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients
4. Progressive disease after high-dose chemotherapy and autologous marrow transplantation for lymphoid malignancy: clinical course and patient follow-up
5. Second HLA-identical sibling transplants for leukemia recurrence
6. Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission
7. Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft
8. Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant
9. Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation
10. Salvage autologous or allogeneic transplantation for multiple myeloma refractory to or relapsing after a first-line autograft?
11. Patients with mantle-cell lymphoma relapsing after autologous stem cell transplantation may be rescued by allogeneic transplantation
12. Bone marrow transplantation
13. Graft-versus-leukemia reactions after bone marrow transplantation
14. Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation
15. Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma
16. Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect
17. Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantation
18. Successful allogeneic bone marrow transplantation for early relapse after autologous bone marrow transplantation in two cases of aggressive high-grade non-Hodgkin's lymphoma
19. Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma
20. Allogeneic stem cell transplantation as salvage or consolidation therapy after prior melphalan based autotransplantation for poor risk multiple myeloma
21. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases
22. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies